NCT00392054 - First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Atrial Fibrillation

Interventions

PROCEDURE

Pulmonary Vein Isolation performed by Catheter Ablation

Ablation will be done to achieve entrance block into all pulmonary veins.

DRUG

Conventional Antiarrhythmic Drug Therapy

Anti-Arrhythmic Drugs per ACC/AHA 2006 Guidelines for the Management of Patients with AF

Trial Locations (16)

70021

F. Miulli Hospital, Acquaviva delle Fonti

78705

Texas Cardiac Arrhythmia Foundation, Austin

78756

Austin Heart, Austin

79188

Abteilung Rhythmologie, Bad Krozingen

Asklepios Klinik St. Georg, Hamburg

V8R 4R2

Victoria Cardiac Arrhythmia Trials Inc., Victoria

L8L 2X2

Hamilton General Hospital, Hamilton

N6A 5A5

London Health Sciences Centre University Hospital, London

L3Y 2P9

Southlake Regional Health Centre, Newmarket

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

H1T 1C8

Montreal Heart Institute, Montreal

H3G 1A4

McGill University, Montreal

G1V 4G5

Institut Universitaire de Cardiologie et Pneumologie de Québec, Québec

Unknown

Institute for Clinical and Experimental Medicine, Prague

Charles University, Prague

D-20246

University Hospital Eppendorf, Hamburg